RTN has developed an effective, successful treatment programme designed to address anxiety, combining cognitive behavioural and nature therapy with mindfulness-based interventions (MBIs) and daily support.
Anxiety is highly treatable; in most cases, individuals can address their anxiety without leaving the comfort of their home or even their place of work. Recovery Through Nature currently has a success rate of over 90% treating most anxieties.
RTN is currently offering an intensive 10-day treatment programme, including daily therapy sessions (45 minutes) with a qualified Recovery Through Nature therapist and full treatment support by our subject-specific professionals.
This treatment programme has limited availability due to the intensity and involvement required of the RTN team members. We are dedicated to providing you with 24-hour service, adjusting your treatment to your work schedule.
Furthermore, pharmacotherapy is not free from concern, as the repeated use of medication can lead to habituation (especially in long-term treatments) and present side effects and drug interactions, among other problems. Therefore, there is a need for more effective, safer methods to address anxiety.
Cognitive behavioural therapy (CBT) is the most well-supported psychotherapy used to treat anxiety disorders, but it can be difficult to access and even unavailable in some geographic regions due to a lack of trained providers. Even when available, patients do not always follow up – in a study on anxiety disorders that examined pre-treatment attrition rates, approximately 30% of patients who were referred to CBT by doctors did not end up undergoing treatment.
Additionally, CBT is typically provided in a mental health treatment setting, such as a psychiatric clinic, which is unfortunately linked with negative stigmas. Approximately 10–20% of adult patients report the stigmas surrounding mental illness as a reason for not pursuing mental health treatment. This has led to an increase in the attention received by complementary and alternative interventions.
Anxiety disorders – including generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), and agoraphobia – are the most common psychiatric conditions in the US, with a lifetime prevalence of approximately 30%.
Anxiety illnesses rank in the top ten causes of disability worldwide and are the most widespread psychiatric condition in Europe. Over 60 million people currently suffer from anxiety related symptoms - a number that has steadily increased over the last decade.
Selective serotonin reuptake inhibitor antidepressants (SSRIs) are considered first-line medication treatment options for anxiety disorders; however, they are only partially effective. Approximately half of the patients fail to reach long-term recovery from anxiety, and many more do not adhere to their prescribed drug regimen. For example, one antidepressant adherence study found that only about half of patients who began using an SSRI accessed their first prescription refill.